Are you Dr. Bendapudi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 79 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-726-2862
Summary
- Dr. Pavan Bendapudi, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Florida. He is affiliated with Massachusetts General Hospital and is a Clinical Fellow in Pathology at Brigham and Women's Hospital.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2015- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Blood Banking/Transfusion Medicine, 2011 - 2012
Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
Stanford University School of MedicineClass of 2008
Certifications & Licensure
MA State Medical License 2010 - 2025
FL State Medical License 2021 - 2023- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 3 citationsLow-frequency inherited complement receptor variants are associated with purpura fulminans.Pavan K Bendapudi, Sumaiya Nazeen, Justine Ryu, Onuralp Söylemez, Alissa Robbins
Blood. 2024-03-14 - 855 citationsCOVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.Hanny Al-Samkari, Rebecca Karp Leaf, Walter H. Dzik, Jonathan C. T. Carlson, Annemarie E. Fogerty
Blood. 2020-07-23 - 34 citationsImpact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in NSCLC.Hanny Al-Samkari, Orly Leiva, Ibiayi Dagogo-Jack, Alice T. Shaw, Jochen K. Lennerz
Journal of Thoracic Oncology. 2020-09-01
Press Mentions
Newer Blood Thinners Surpass Warfarin for Treating Seniors with Afib and Prior StrokeApril 14th, 2022- Clinicians Report Success with First Test of Drug in a Patient with Life-Threatening Blood Clotting DisorderMay 17th, 2024
- Medical Professionals See Positive Results in Initial Trial of Medication for Severe Blood Clotting DisorderMay 19th, 2024
